disclosure
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Ltd) has informed the stock exchanges that its trading window will be closed for all Directors, Promoters, Key Managerial Personnel (KMPs), other Designated Persons/employees, and their immediate relatives starting from Thursday, 01st January 2026, until 48 hours after the Un-audited Financial Results for the quarter ending 31st December 2025 are declared to the stock exchange and made public. This closure is pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's own insider trading code. The exact date of the Board of Directors meeting to approve the December quarter results will be communicated to the exchanges later. The intimation is signed by Pooja Chuni, Company Secretary, and is dated 29th December 2025.
This is a routine compliance filing and does not have a direct material impact on shareholders. However, it signals that the Q3 FY26 (October-December 2025) unaudited results are upcoming, and insiders cannot trade in the company's shares during this blackout period, which is standard practice before earnings announcement.